10-K/A: Merck & Co. Amends Annual Report to Correct Shareholder Meeting Date
Annual Report Amendment
Merck & Co. has filed an amendment to its annual report to correct the date of the annual shareholder meeting from May 18, 2024 to May 28, 2024.
Summary
- Merck & Co. has filed an amendment to its annual report on Form 10-K for the fiscal year ended December 31, 2023.
- The sole purpose of this amendment is to correct the date of the Annual Meeting of Shareholders, which was incorrectly stated as May 18, 2024, in the original filing.
- The correct date for the Annual Meeting of Shareholders is May 28, 2024.
- This amendment also includes updated certifications from the principal executive officer and principal financial officer.
- The amendment does not reflect any events occurring after the filing of the original report or modify any other disclosures.
Sentiment
Score: 10
Explanation: The document is a routine correction of a minor error and has no negative implications for the company. It is a standard administrative process.
Management Comments
- Caroline Litchfield, Executive Vice President and Chief Financial Officer, certified that the report does not contain any untrue statement of a material fact.
- Robert M. Davis, Chairman, Chief Executive Officer and President, certified that the report does not contain any untrue statement of a material fact.
Industry Context
This is a routine amendment to correct a clerical error in the filing of an annual report, which is a common occurrence for publicly traded companies.
Comparison to Industry Standards
- The filing of an amendment to correct a date is a standard practice in corporate reporting.
- Many companies file amendments to their annual reports for various reasons, including correcting errors or updating information.
- The process of filing a 10-K/A is well-defined by the SEC, and Merck's actions are consistent with these regulations.
Stakeholder Impact
- Shareholders are informed of the correct date for the Annual Meeting of Shareholders.
- The amendment ensures accurate information is available to all stakeholders.
Next Steps
- The company will hold its Annual Meeting of Shareholders on May 28, 2024.
- Shareholders should refer to the proxy statement for details regarding the meeting.
Key Dates
| Date | Description |
|---|---|
| 2023-12-31 | End of the fiscal year covered by the original annual report. |
| 2024-01-31 | Date used to calculate the number of outstanding shares of common stock. |
| 2024-02-26 | Date the original Form 10-K was filed. |
| 2024-04-11 | Date of this amendment filing. |
| 2024-05-28 | Corrected date of the Annual Meeting of Shareholders. |
Keywords
Annual Report, Amendment, Shareholder Meeting, Form 10-K, Merck, Corporate Governance
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.